Legal Opinion
Impax Laboratories Inc. v. Lannett Holdings Inc.
Court of Appeals for the Federal Circuit
Decided June 28, 2018No. 2017-2020PublishedCited by 13 opinions
1Opinion of the Court
Lourie, Circuit Judge.
*1375 Lannett Holdings Inc. and Lannett Co. Inc. (together, "Lannett") appeal from the decision of the United States District Court for the District of Delaware concluding, after a bench trial, that claims 4, 11, 12, and 14 of U.S. Patent 6,750,237 ("the '237 patent") and claims 6 and 14-16 of U.S. Patent 7,220,767 ("the '767 patent") were not shown to be invalid, see Impax Labs., Inc. v. Lannett Holdings Inc. , 246 F.Supp.3d 1024 (D. Del. 2017) (" Opinion "), entering judgment in favor of Impax Laboratories Inc. ("Impax"), AstraZeneca AB, and AstraZeneca UK Limited…
2Cases cited17 opinions
- United States v. United States Gypsum Co.Supreme Court of the United States · 1948
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Microsoft Corp. v. i4i Ltd. PartnershipSupreme Court of the United States · 2011
- Teva Pharm. United States, Inc. v. Sandoz, Inc.Supreme Court of the United States · 2015
12 more not listed; retrieve them via the Exa API.
3Cited by13 opinions
- United Cannabis Corporation v. Pure Hemp Collective Inc.Court of Appeals for the Federal Circuit · 2023
- Esip Series 2, LLC v. Puzhen Life USA, LLCCourt of Appeals for the Federal Circuit · 2020
- Roku, Inc. v. Universal Electronics, Inc.Court of Appeals for the Federal Circuit · 2023
- Apple Inc. v. voip-pal.com, Inc.Court of Appeals for the Federal Circuit · 2020
- B/E Aerospace, Inc. v. C&D Zodiac, IncCourt of Appeals for the Federal Circuit · 2020
8 more not listed; retrieve them via the Exa API.